John Carreyrou: Bad Blood (A Union League Club Event)

We are delighted to be on hand as the Union League Club hosts Pulitzer Prize winner John Carreyrou for a luncheon event where he will discuss and sign copies of his award-winning book Bad Blood: Secrets and Lies in a Silicon Valley Startup. (new in paperback!)  This is a ticketed event. Call us at The Book Stall (847-446-8880) to make your reservation or to secure an autographed copy. 

Please note that the Club has a dress code; no denim or leisure wear please.

About the book: 

  • The Financial Times & McKinsey Business Book of the Year
  • New York Times Notable Book
  • Washington Post Notable Book

One of the Best Books of the Year: NPR, San Francisco ChronicleTimeEsquireFortuneMarie ClaireGQMental FlossScience FridayBloombergPopular MechanicsBookRiotThe Seattle TimesThe OregonianPublishers WeeklyLibrary Journal

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings--from journalists to their own employees.

Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron--a tale of ambition and hubris set amid the bold promises of Silicon Valley.

"A great and at times almost unbelievable story. . . . Theranos may be the biggest case of corporate fraud since Enron." -- New York

"Chilling. . . . Reads like a thriller. . . . Carreyrou tells [the Theranos story] virtually to perfection." -- The New York Times Book Review

"Gripping. . . . Riveting. . . . [Told] with a momentum worthy of a crime novel." -- Los Angeles Review of Books

"Riveting. . . . For all its boomtime feel, there are timeless aspects to Theranos' story. Venality is age-old, but so is courage, and that of the ex-employees who blew the whistle on its deceptions is restorative. . . . And more than an honorable mention should go to Carreyrou, a dogged old-school reporter uncowed by Theranos' legal hardball." -- San Francisco Chronicle

"Engrossing. . . . Hard to put down. . . . Boasts movie-scene detail. . . . Theranos employees are the story's heroes, with the force of journalism not far behind." -- Science

"A veritable page-turning. . . . Gripping. . . . Presents comprehensive evidence of the fraud perpetrated by Theranos chief executive Elizabeth Holmes... Unveils many dark secrets of Theranos that have not previously been laid bare." -- Nature

"This is a 'stay up all night to read' book that is just as propulsive, shocking, and riveting as the best thriller novels." -- Bustle

About the author: 

John Carreyrou, a two-time Pulitzer Prize winner, was a reporter at The Wall Street Journal for twenty years. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. Bad Blood was named the Financial Times and McKinsey Business Book of the Year. Carreyrou lives in Brooklyn, New York, with his wife and three children.

Event date: 

Monday, February 3, 2020 - 11:30am to 1:00pm

Event address: 

The Union League Club
65 W Jackson Blvd
Chicago, IL 60604
Bad Blood: Secrets and Lies in a Silicon Valley Startup Cover Image
$16.95
ISBN: 9780525431992
Availability: On Our Shelves Now--Subject to Availability
Published: Vintage - January 28th, 2020

The Financial Times & McKinsey Business Book of the Year
 
A New York Times Notable Book
A Washington Post Notable Book